Role of α7 nicotinic receptors in nicotine dependence and implications for psychiatric illness

Behavioural Brain Research

Volumn 113, Issue 1-2, 2000, Pages 97-103

  Nomikos, George G ^a   Schilström, Björn ^b   Hildebrand, Bengt E ^b   Panagis, George ^b   Grenhoff, Johan ^b   Svensson, Torgny H ^b  

^a ELI LILLY AND COMPANY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dopamine; Medial prefrontal cortex; Mesolimbocortical; Methyllycaconitine; Nucleus accumbens; Ventral tegmental area

Indexed keywords

DOPAMINE; MECAMYLAMINE; METHYLLYCACONITINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR;

ARTICLE; DOPAMINE RELEASE; MENTAL DISEASE; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE CELL; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SUBSTANCE ABUSE; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME; ANIMAL; BRAIN; BRAIN MAPPING; HUMAN; MOTIVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SCHIZOPHRENIA; TOBACCO DEPENDENCE;

ANIMALS; BRAIN; BRAIN MAPPING; DOPAMINE; HUMANS; MOTIVATION; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

EID: 0033626287     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00204-7     Document Type: Article

References (65)

1. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215.
2. Briggs C.A., McKenna D.G. Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology. 35(4):1996;407-414.
3. Bunney B.S. Clozapine: a hypothesised mechanism for its unique clinical profile. Br. J. Psychiatry. 160(Suppl. 17):1992;17-21.
4. Charléty P.J., Grenhoff J., Chergui K., de la Chappelle B., Buda M., Svensson T.H., Chouvet G. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiol. Scand. 142:1991;105-112.
5. Charpantier E., Barneoud P., Moser P., Besnard F., Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport. 9:1998;3097-3101.
6. Chergui K., Charléty P.J., Akaoka H., Saunier C.F., Brunet J.-L., Buda M., Svensson T.H., Chouvet G. Tonic activation of NMDA receptors causes spontaneous bursts discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5:1993;137-144.
7. Chergui K., Nomikos G.G., Mathé J.M., Gonon F., Svensson T.H. Burst stimulation of the medial forebrain bundle selectively increases Fos-like immunoreactivity in the limbic forebrain of the rat. Neuroscience. 72:1996;141-156.
8. Chergui K., Svenningsson P., Nomikos G.G., Gonon F., Fredholm B., Svensson T.H. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain. Eur. J. Neurosci. 9:1997;2370-2382.
9. Clarke P.B.S., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246:1988;701-708.
10. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
11. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
12. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic dopamine system of freely moving rats. Proc. Natl. Acad. Sci. 85:1988;5274-5278.
13. Dominguez del Toro E., Juiz J.M., Peng X., Lindstrom J., Criado M. Immunocytochemical localization of the α7 subunit of the nicotinic acetycholine receptor in the rat central nervous system. J. Comp. Neurol. 349:1994;325-342.
14. Fibiger H.C., Phillips A.G. Reward, motivation, cognition: psychobiology of the mesotelencephalic dopamine systems. Bloom F.E. Handbook of Physiology, Section I: The Nervous System. IV:1986;647-675 American Physiological Society, Bethesda, MD.
15. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. 94(2):1997;587-592.
16. Glassman A.H. Cigarette smoking. Implications for psychiatric illness. Am. J. Psychiatry. 150:1993;546-553.
17. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
18. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
19. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand. 128:1986;351-358.
20. Grenhoff J., Tung C.-S., Svensson T.H. The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 134:1988;567-568.
21. Grenhoff J., Svensson T.H. Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol. Scand. 133:1988;595-596.
22. Guan Z.-Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor α7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 10:1999;1779-1782.
23. Hildebrand B.E., Nomikos G.G., Bondjers C., Nisell M., Svensson T.H. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology. 129:1997;348-356.
24. Hildebrand B.E., Nomikos G.G., Hertel P., Schilström B., Svensson T.H. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine precipitated nicotine withdrawal syndrome. Brain Res. 779:1998;214-225.
25. Hildebrand B.E., Panagis G., Svensson T.H., Nomikos G.G. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat:role of nicotinic receptors in the rat. Neuropsychopharmacology. 21:1999;560-574.
26. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
27. Imperato A., Mulas A., DiChiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:1986;337-338.
28. Ingvar D.H. Evidence for frontal/prefrontal cortical dysfunction in chronic schizophrenia: the phenomenon of hypofrontality reconsidered. Helmchen H., Henn F.A. Biological Prespectives of Schizophrenia. 1987;201-211 Wiley, New York.
29. Kiba H., Jayaraman A. Nicotine-induced c-fos expression in the striatum is mediated mostly by D1 receptor and is dependent on NMDA stimulation. Mol. Brain Res. 23:1994;1-13.
30. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
31. Leikola-Pelho T., Jackson D.M. Preferential stimulation of locomotor activity by ventral tegmental microinjections of (-)-nicotine. Pharmacol. Toxicol. 70:1992;50-52.
32. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophrenia Bull. 22(3):1996;431-445.
33. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Res. 8:1992;93-102.
34. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
35. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157:1993;53-56.
36. Murase S., Mathe J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions related to anatomical localization. J. Neural Transm. 91:1993;13-25.
37. Museo E., Wise R.A. Sensitization of locomotion following repeated ventral tegmental injections of cytisine. Pharmacol. Biochem. Behav. 4:1994;521-524.
38. Museo E., Wise R.A. Place preference conditioning with ventral tegmental injections of cytisine. Life Sci. 55(15):1994;1179-1186.
39. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
40. Nisell M., Nomikos G.G., Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol. Toxicol. 75:1994;348-352.
41. Nisell M., Nomikos G.G., Hertel P., Panagis G., Svensson T.H. Condition-independent sensitization in locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse. 22:1996;369-381.
42. Nisell M., Nomikos G.G., Chergui K., Grillner P., Svensson T.H. Chronic nicotine enhances basal and nicotine-induced Fos-immunoreactivity preferentially in the medial preforntal cortex of the rat. Neuropsychopharmacology. 17:1997;151-161.
43. Nomikos G.G., Svenningsson P., Panagis G., Schilström B., Fredholm B.B., Svensson T.H. Chronic nicotine-induced sensitization of locomotor activity in the rat is associated with an increase in c-fos and NGFI-A mRNA levels preferentially in the medial prefrontal cortex. Soc. Neurosci. Abstracts. 24:1998;751.
44. Nomikos G.G., Hildebrand B.E., Panagis G., Svensson T.H. Nicotine withdrawal syndrome in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroreport. 10:1999;697-702.
45. Nomikos G.G., Panagis G., Kastellakis A., Southall S.S., Spyraki C. Role of alpha7 nicotinic receptors in the reinforcing actions of nicotine. Soc. Neurosci. Abstracts. 25:1999;1980.
46. Panagis G., Nisell M., Nomikos G.G., Chergui K., Svensson T.H. Nicotine injections in the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res. 730:1996;133-142.
47. Panagis G., Hildebrand B.E., Svensson T.H., Nomikos G.G. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Synapse. 35(1):2000;15-25.
48. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Merlo-Pich E., Fuxe K., Changeux J.P. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177.
49. Pidoplichko V., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
50. Reavill C., Stolerman I.P. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br. J. Pharmacol. 99:1990;273-278.
51. Ren T., Hagar S.M. Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res. Bull. 29:1992;589-597.
52. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. NMDA receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1998;781-789.
53. Schilström B., Nomikos G.G., Fagerquist M.V., Zhang X., Hertel P., Panagis G., Svensson T.H. Nicotine-mediated presynaptic regulation of glutamate release in the ventral tegmental area. Soc. Neurosci. Abstracts. 24:1998;333.
54. Schilström B., Svensson H.M., Svensson T.H., Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: role of α7 nicotinic receptors in the ventral tegmental area. Neuroscience. 85(4):1998;1005-1009.
55. Schilström B, De Villiers S, Malmerfelt A, Svensson TH, Nomikos GG. Nicotine induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area. Synapse 2000;in press.
56. Schultz W. Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. J. Neurophysiol. 56:1986;1439-1462.
57. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13(3):1993;900-913.
58. Shoaib M., Benwell M.E.M., Akbar M.T., Stolerman I.P., Balfour D.J.K. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br. J. Pharmacol. 111:1994;1073-1080.
59. Svensson T.H., Tung C.-S. Local cooling of prefrontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 136:1989;135-136.
60. Tung C.-S., Grenhoff J., Svensson T.H. Nicotine counteracts midbrain dopamine cell dysfunction induced by prefrontal cortex inactivation. Acta Physiol. Scand. 138:1990;427-428.
61. Vezina P., Blanc G., Glowinski J., Tassin J.-P. Nicotine and morphine differentially active brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J. Pharmacol. Exp. Ther. 261(2):1992;484-490.
62. Vidal C., Changeux J.-P. Neuronal nicotinic acetylcholine receptors in the brain. News Physiol. Sci. 11:1996;202-208.
63. Wise R.A., Bozarth M.A. A psychomotor theory of addiction. Psychol. Rev. 94:1987;469-492.
64. Zhang X., Nordberg A. Characterization of nicotinic acetylcholine receptors in brain. Domino E.F. Brain Imaging and Tobacco Smoking. 1995;59-71 NPP Books, Ann Arbor, MI.
65. Yeomans J.S. Role of tegmental cholinegic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology. 12:1995;3-16.